Skip to main content

Find Clinical Trials

Home
Conditions
Esophagitis, Peptic

Clinical trial condition

Esophagitis, Peptic

Explore clinical trials studying Esophagitis, Peptic. Study availability and eligibility vary by location and protocol.

62 public trials 6 recruiting studies

Refine in advanced search Browse all conditions

Esophagitis, Peptic trial results

Completed

Impact of Timing on the Efficacy of Zegerid 40 mg in Healing Reflux Esophagitis: A Pilot Study

NCT00693225

Conditions: Deglutition Disorders, Digestive System Diseases, Duodenal Diseases, +11 more
Locations: Mayo Clinic Rochester, Minnesota, United States

View Trial Details

Completed

Analysis of Biopsies From the Upper Gastrointestinal Tract

NCT01576289

Conditions: Barrett Esophagus, Deglutition Disorders, Digestive System Diseases, +15 more
Locations: Medical University Graz, Austria

View Trial Details

Completed

Effect of Repeated Doses of YF476, Omeprazole and Placebo on Stomach Acidity in Healthy Volunteers

NCT01599858

Conditions: Digestive System Diseases, Duodenal Diseases, Esophageal Diseases, +8 more
Locations: Hammersmith Medicines Research London, United Kingdom

View Trial Details

Completed

Effect of 5, 10 or 25 mg of YF476 Daily for 14 Days on Stomach Acidity in Healthy Volunteers

NCT01597674

Conditions: Digestive System Diseases, Duodenal Diseases, Esophageal Diseases, +8 more
Locations: Hammersmith Medicines Research London, United Kingdom

View Trial Details

Completed

Double-blind Comparative Study of E3810 Tablets (10 or 20 mg b.i.d.) to Evaluate Efficacy and Safety in Patients With Refractory Reflux Esophagitis

NCT00770913

Conditions: Deglutition Disorders, Digestive System Diseases, Duodenal Diseases, +11 more
Locations: Nagakute, Aichi-ken, Japan

Nagoya, Aichi-ken, Japan

Akita, Japan

Abiko, Chiba, Japan

View all 54 locations

View Trial Details

Completed

Effect of Single Doses of YF476 on Stomach Acidity Compared With Ranitidine and Placebo in Fasted and Fed States

NCT01538797

Conditions: Digestive System Diseases, Duodenal Diseases, Esophageal Diseases, +8 more
Locations: Hammersmith Medicines Research London, United Kingdom

View Trial Details

Completed

Safety, Tolerability and Pharmacokinetics of Single Rising Doses of YF476, a Gastrin Antagonist, in Healthy Men

NCT01538784

Conditions: Digestive System Diseases, Duodenal Diseases, Esophageal Diseases, +8 more
Locations: Hammersmith Medicines Research London, United Kingdom

View Trial Details

Completed

Analysis of GERD Symptoms Using Gastroesophageal Reflux Impact Score Questionnaire for Quality of Life

NCT01536080

Conditions: Deglutition Disorders, Digestive System Diseases, Duodenal Diseases, +14 more
Locations: Seoul National University Bundang Hospital Bundang-gu, Seongnam, Gyeonggi-do, South Korea

View Trial Details

Completed

Efficacy and Safety of Dexlansoprazole MR Compared to Placebo on Maintaining Healing in Subjects With Healed Erosive Esophagitis

NCT00321737

Conditions: Digestive System Diseases, Duodenal Diseases, Esophageal Diseases, +8 more
Locations: Huntsville, Alabama, United States

Tuscon, Arizona, United States

Anaheim, California, United States

Azusa, California, United States

View all 98 locations

View Trial Details

Completed

Efficacy and Safety of Dexlansoprazole MR on Maintaining Healing in Subjects With Healed Erosive Esophagitis

NCT00255164

Conditions: Digestive System Diseases, Duodenal Diseases, Esophageal Diseases, +8 more
Locations: Alabaster, Alabama, United States

Birmingham, Alabama, United States

Huntsville, Alabama, United States

Phoenix, Arizona, United States

View all 96 locations

View Trial Details